Literature DB >> 30240112

Cleft palate and hypopituitarism in a patient with Noonan-like syndrome with loose anagen hair-1.

Natario L Couser1,2,3, Debra Keelean-Fuller2, Marsha L Davenport4, Eden Haverfield5, Maheer M Masood6, Mark Henin4, Arthur S Aylsworth2,7.   

Abstract

Noonan syndrome (NS), the most common of the RASopathies, is a developmental disorder caused by heterozygous germline mutations in genes encoding proteins in the RAS-MAPK signaling pathway. Noonan-like syndrome with loose anagen hair (NSLH, including NSLH1, OMIM #607721 and NSLH2, OMIM #617506) is characterized by typical features of NS with additional findings of macrocephaly, loose anagen hair, growth hormone deficiency in some, and a higher incidence of intellectual disability. All NSLH1 reported cases to date have had an SHOC2 c.4A>G, p.Ser2Gly mutation; NSLH2 cases have been reported with a PPP1CB c.146G>C, p.Pro49Arg mutation, or c.166G>C, p.Ala56Pro mutation. True cleft palate does not appear to have been previously reported in individuals with NS or with NSLH. While some patients with NS have had growth hormone deficiency (GHD), other endocrine abnormalities are only rarely documented. We present a female patient with NSLH1 who was born with a posterior cleft palate, micrognathia, and mild hypotonia. Other findings in her childhood and young adulthood years include hearing loss, strabismus, and hypopituitarism with growth hormone, thyroid stimulating hormone (TSH), and gonadotropin deficiencies. The SHOC2 mutation may be responsible for this patient's additional features of cleft palate and hypopituitarism.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  zzm321990PPP1CB; zzm321990SHOC2; NS; NS/LAH; NSLH; Noonan syndrome; Noonan-like syndrome with loose anagen hair; RAS-MAPK; cleft palate; hypopituitarism

Mesh:

Substances:

Year:  2018        PMID: 30240112     DOI: 10.1002/ajmg.a.40432

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  7 in total

1.  The role of USP7 in the Shoc2-ERK1/2 signaling axis and Noonan-like syndrome with loose anagen hair.

Authors:  Patricia Wilson; Lina Abdelmoti; Rebecca Norcross; Eun Ryoung Jang; Malathy Palayam; Emilia Galperin
Journal:  J Cell Sci       Date:  2021-11-05       Impact factor: 5.285

2.  Osmotic demyelination syndrome in a patient with Noonan syndrome and anterior hypopituitarism.

Authors:  Tzy Harn Chua; Wann Jia Loh
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2020-08-20

3.  Ras signaling and RREB1 are required for the dissociation of medial edge epithelial cells in murine palatogenesis.

Authors:  Toshihiro Inubushi; Ayaka Fujiwara; Takumi Hirose; Gozo Aoyama; Toshihiro Uchihashi; Naoki Yoshida; Yuki Shiraishi; Yu Usami; Hiroshi Kurosaka; Satoru Toyosawa; Susumu Tanaka; Tetsuro Watabe; Mikihiko Kogo; Takashi Yamashiro
Journal:  Dis Model Mech       Date:  2022-02-15       Impact factor: 5.758

4.  Case report: Identification and clinical phenotypic analysis of novel mutation of the PPP1CB gene in NSLH2 syndrome.

Authors:  Xuemei He; Xiuli Ma; Jing Wang; Zhuo Zou; Haoyu Huang; Jian Ren; Chunming Liu; Nan Zheng; Jing Ma; Yun Liu
Journal:  Front Behav Neurosci       Date:  2022-09-08       Impact factor: 3.617

Review 5.  Inside the Noonan "universe": Literature review on growth, GH/IGF axis and rhGH treatment: Facts and concerns.

Authors:  Stefano Stagi; Vittorio Ferrari; Marta Ferrari; Manuela Priolo; Marco Tartaglia
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-18       Impact factor: 6.055

6.  Integrated in silico MS-based phosphoproteomics and network enrichment analysis of RASopathy proteins.

Authors:  Javier-Fernando Montero-Bullón; Óscar González-Velasco; María Isidoro-García; Jesus Lacal
Journal:  Orphanet J Rare Dis       Date:  2021-07-06       Impact factor: 4.123

7.  A phenome-wide association study of 26 mendelian genes reveals phenotypic expressivity of common and rare variants within the general population.

Authors:  Catherine Tcheandjieu; Matthew Aguirre; Stefan Gustafsson; Priyanka Saha; Praneetha Potiny; Melissa Haendel; Erik Ingelsson; Manuel A Rivas; James R Priest
Journal:  PLoS Genet       Date:  2020-11-23       Impact factor: 5.917

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.